COM:EVAXION-BIOTECH
Evaxion Biotech A/S
- Stock
Last Close
1.39
22/11 21:00
Market Cap
16.59M
Beta: -
Volume Today
13.33K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | -682.50K - | -682.50K 0% | -3.46M 406.23% | -4.41M 27.51% | -950.50K 78.42% | -1.25M 31.20% | ||
average payables | 99K - | 392.50K 296.46% | 1.65M 319.36% | 2.75M 66.89% | 2.47M 10.21% | 2.39M 3.22% | ||
average receivables | 1.45M - | 851.50K 41.46% | 1.36M 60.01% | 1.85M 35.60% | 1.34M 27.20% | 931.98K 30.71% | ||
book value per share | -0.05 - | 0.49 1,105.59% | 0.43 10.90% | -2.59 695.46% | -3.07 18.81% | -1.73 43.72% | ||
capex per share | -0.00 - | -0.00 771.43% | -0.02 663.58% | -0.07 187.57% | -0.01 82.29% | -0.03 158.04% | ||
capex to depreciation | -0.09 - | -0.75 696.12% | -3.74 397.00% | -3.95 5.63% | -0.51 87.07% | -0.14 72.34% | ||
capex to operating cash flow | 0.00 - | 0.01 146.94% | 0.03 263.93% | 0.06 96.25% | 0.01 81.73% | 0.00 56.59% | ||
capex to revenue | -1.19 - | |||||||
cash per share | 0.39 - | 0.50 28.60% | 0.36 27.67% | 1.65 358.17% | 0.56 66.20% | 2.04 266.18% | ||
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | 5.37K - | |||||||
debt to assets | 0.05 - | 1.02 1,753.51% | 0.00 99.68% | 0.00 48.54% | 0.09 5,396.46% | -0.04 141.64% | 0.70 1,919.74% | |
debt to equity | 0.06 - | -9.31 14,755.29% | 0.00 100.04% | 0.00 26.10% | -0.07 2,674.78% | -0.03 57.58% | -1.90 6,014.48% | |
dividend yield | 0.00 - | |||||||
earnings yield | -0.03 - | -0.06 102.26% | -0.09 58.99% | -0.28 203.73% | -0.55 93.39% | -1.18 114.60% | ||
enterprise value | -306K - | 191.11M 62,554.19% | 180.35M 5.63% | 154.39M 14.39% | 57.68M 62.64% | 31.15M 46.00% | 24.04M 22.82% | |
enterprise value over ebitda | -34.43 - | -16.74 51.37% | -9.44 43.60% | -2.42 74.32% | -1.39 42.72% | -1.11 19.90% | ||
ev to operating cash flow | -95.99 - | -25.67 73.26% | -12.41 51.64% | -2.63 78.81% | -1.21 54.05% | -1.36 12.27% | ||
ev to sales | 328.80 - | |||||||
free cash flow per share | -0.10 - | -0.37 254.70% | -0.79 114.58% | -1.19 50.86% | -1.10 7.72% | -6.51 490.70% | ||
free cash flow yield | -0.01 - | -0.04 254.70% | -0.08 114.58% | -0.27 237.55% | -0.62 129.14% | -0.95 53.27% | ||
graham net net | -0.11 - | 0.44 503.65% | -0.07 116.70% | 1.28 1,821.78% | 0.00 99.82% | -4.11 180,747.25% | ||
graham number | 0.56 - | 2.53 350.99% | 3.01 19.02% | 8.56 184.31% | 8.23 3.81% | 17.76 115.75% | ||
income quality | 0.36 - | 0.63 74.47% | 0.83 31.96% | 0.89 7.95% | 1.11 24.43% | 0.80 28.12% | ||
intangibles to total assets | 0 - | 0 | 0 | 0.01 Infinity% | 0.00 72.29% | 0 100% | 0 | |
interest coverage | -8.06 - | -8.89 10.27% | -74.30 735.77% | -28.23 62.00% | -16.75 40.66% | -17.74 5.91% | ||
interest debt per share | 0.49 - | 0.07 86.57% | 0.02 77.11% | 0.24 1,474.78% | 0.16 32.62% | 3.74 2,250.12% | ||
inventory turnover | ||||||||
invested capital | 0.06 - | -9.31 14,755.29% | 0.00 100.04% | 0.00 26.10% | -0.07 2,674.78% | -0.03 57.58% | -1.90 6,014.48% | |
market cap | 189.87M - | 189.87M 0% | 160.20M 15.63% | 86.16M 46.22% | 42.08M 51.16% | 18.75M 55.43% | ||
net current asset value | 2.34M - | -1.06M 145.36% | 9.24M 970.50% | 907K 90.18% | 26.98M 2,874.53% | 251K 99.07% | -9.27M 3,792.32% | |
net debt to ebitda | -0.22 - | 0.88 497.32% | 0.36 59.78% | 1.20 236.58% | 0.49 59.29% | -0.24 150.20% | ||
net income per share | -0.29 - | -0.58 102.26% | -0.93 58.99% | -1.26 35.74% | -0.98 22.12% | -8.11 727.06% | ||
operating cash flow per share | -0.10 - | -0.37 252.89% | -0.77 109.81% | -1.13 46.54% | -1.09 3.10% | -6.48 494.47% | ||
payables turnover | ||||||||
receivables turnover | 0.07 - | |||||||
research and ddevelopement to revenue | 158.58 - | |||||||
return on tangible assets | -0.65 - | -1.01 55.34% | -1.27 25.32% | -0.61 51.63% | 0.39 164.21% | -1.72 537.35% | ||
revenue per share | 0.03 - | |||||||
roe | 5.95 - | -1.20 120.11% | -2.13 78.45% | 0.49 122.80% | 0.32 34.45% | 4.69 1,369.52% | ||
roic | -0.63 - | -1.07 69.18% | -2.12 97.76% | 0.58 127.35% | 0.36 38.14% | -3.50 1,074.30% | ||
sales general and administrative to revenue | ||||||||
shareholders equity per share | -0.05 - | 0.49 1,105.59% | 0.43 10.90% | -2.59 695.46% | -3.07 18.81% | -1.73 43.72% | ||
stock based compensation to revenue | ||||||||
tangible asset value | 2.55M - | -931K 136.51% | 9.36M 1,105.59% | 6.94M 25.89% | 32.34M 366.19% | -72.66M 324.64% | -4.73M 93.49% | |
tangible book value per share | -0.05 - | 0.49 1,105.59% | 0.43 12.17% | 1.66 287.40% | -3.07 285.25% | -1.73 43.72% | ||
working capital | 2.44M - | -1.04M 142.59% | 9.24M 990.65% | 907K 90.18% | 30.38M 3,249.72% | 10.21M 66.39% | 1.27M 87.60% |
All numbers in USD (except ratios and percentages)